Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
March 14, 2024 07:30 ET
|
Purple Biotech Ltd.
Contribution of NK cells engager arm and conditionally activated T cell engager demonstrated Cleavable capping technology confines therapeutic activity to the local tumor micro environment which...